Tag: Europe
-
Alliance Creating PTSD Knowledge Base
11 February 2016. A collaboration of three organizations and companies in the U.S. and Germany is building an authoritative and systematic collection of research on post-traumatic stress disorder or PTSD. The PTSD KnowledgeMap, as it’s called, is a project of Cohen Veterans Bioscience, Exaptive Inc,. and Fraunhofer Institute for Algorithms and Scientific Computing, and will…
-
Ebola Monitoring System Devised with Genome Sequencing
3 February 2016. An international team of scientists and engineers designed a mobile system using a hand-held genome sequencing device that provided real-time monitoring of the Ebola outbreak in West Africa in 2015. Researchers led by microbiologists Nicholas Loman and Joshua Quick at University of Birmingham in the U.K. published their findings in today’s (3…
-
Allergan, AstraZeneca Partner on Drug-Resistant Bacteria
29 January 2016. Pharmaceutical companies Allergan and AstraZeneca are developing a new treatment for infections caused by a type of bacteria already resistant to antibiotics. Financial aspects of the collaboration between the enterprises were not disclosed. The agreement calls for the two companies to develop and commercialize ATM-AVI, a new drug that treats infections from…
-
Purdue Licenses Food Pathogen Fingerprint Technology
26 January 2016. A lab equipment company is licensing a laser-based technology developed at Purdue University that quickly identifies foodborne pathogens. Financial aspects of the agreement between Purdue, in West Lafayette, Indiana and Andreas Hettich GmbH in Tuttlingen, Germany were not disclosed. Hettich is acquiring the rights to Bacteria Rapid Detection using Optical Scattering Technology,…
-
Business-Academic Coop to Fund Translational Research
25 January 2016. Three pharmaceutical companies and three universities in the U.K. are forming an independent consortium to support academic research leading to new therapies. The £40 million ($US 57 million) Apollo Therapeutics Fund will be financed by contributions from global pharmaceutical enterprises AstraZeneca, GlaxoSmithKline, and Johnson & Johnson, for work in research labs at…
-
Technique Devised to Improve Stem Cell Harvesting
22 January 2016. Researchers at the Max Delbrück Center for Molecular Medicine in Berlin developed a technique making it easier to detect stem cells and keep active longer in a cell culture. The team from the lab of molecular biologist Zsuzsanna Izsvák published its results in the 21 January issue of the journal Nature Protocols.…
-
Bacterial Bonding Technique Devised to Simplify Vaccines
20 January 2016. Researchers at Oxford University developed and tested engineered proteins from bacteria that in lab tests make vaccine design simpler and more reliable. The team from the lab of biochemistry professor Mark Howarth published its proof-of-concept results in the 19 January issue of Scientific Reports. Howarth — with immunologists from Oxford’s Jenner Institute…
-
Smartphone App Computes Preterm Birth Risk
18 January 2016. A smartphone app based on recently published research aims to calculate the risk of women giving birth prematurely. The app, called Quipp, was designed at King’s College London in the U.K., and is available free of charge for Apple iPhones. The Women’s Health Clinical Academic Group at Kings College developed Quipp —…
-
Computer Game Being Designed to Combat Domestic Violence
15 January 2016. Social scientists and designers in the U.K. are developing a computer game to teach empathy and non-violence in family relationships. The game, for use in the Caribbean and the U.K., is funded by a €400,000 ($US 434,000) grant from the European Commission. The funding, from the EU’s delegation to the Eastern Caribbean…
-
Boehringer, Arena to Discover Neurological Drugs
13 January 2016. Pharmaceutical companies Boehringer Ingelheim and Arena Pharmaceuticals Inc. are collaborating on discovery of new therapies for schizophrenia and other neurological disorders. The partnership could bring Arena, in San Diego, as much as $262 million. Arena Pharmaceuticals is a biopharmaceutical company developing therapies for disorders related to G protein-coupled receptors, or GPCRs, proteins…